[ad_1]
Dr. added. Shaheen, that the company will continue to collect data on the vaccine for the next two years and that the vaccine will be in two doses on the first day and the 22nd.
And Dr. Shaheen, “Preliminary data indicates immunity for at least 3 months, and we are waiting for data on immunity for a period ranging from 6 months to one year. We expect immunity from the vaccine for one year and have started vaccinating a group of children between 12 and 16 years old, and there are plans to vaccinate a group of children under 12 years of age.
Dr. Shaheen is of the importance of excluding the process of obtaining the approval of the health authorities of the policy, since the distribution depends on the approval of the regulatory authorities of each country separately.
“Everyone works at full capacity, but quality takes time. We are looking to secure 1.5 billion doses next year and cooperate with the European Union to allow the vaccine to reach the weakest economic countries, so we hope to sell billions dose in 2021 to include distribution to all countries in the world. “
And the Dr. advised. Shaheen claims to order the vaccine in advance to secure supply chains. “The vaccine is transported at minus 70 degrees, and after transporting the vaccine, it must be stored in special refrigerators available in hospitals.”
American pharmaceutical company Pfizer said last week that its experimental vaccine to treat Covid-19 disease is more than 90% effective, representing a major victory in the battle against the epidemic that has killed more than a million people, devastated the global economy and revolutionized the daily lifestyle.
Pfizer and its partner, German biotechnology company Biontech, are the first pharmaceutical companies to publish successful data from a large-scale clinical trial of a coronavirus vaccine.
And organizers said they would approve a vaccine that is only 50% effective, protecting half of those who receive it. The company says there were no serious side effects.
The discovery that 90% of infections have been prevented by the Pfizer vaccine could excite politicians and public health leaders and potentially end the epidemic.
More than 43,000 people participated in the phase III trials.
The company says it appears that people of black ethnic origin and minorities are just as well protected as the rest.
Pfizer stated that it will take until the third week of November to collect the required safety data, then the file will be sent to the organizers for approval.
According to the company; An expedited leave could mean giving healthcare workers their first doses before the end of the year.
